The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Nov. 30, 2018
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Alexander O. Mujica, Elmsford, NY (US);

Yajun Tang, White Plains, NY (US);

Jeffrey D. Lee, New York, NY (US);

Min Gao, Woodcliff Lake, NJ (US);

Susan D. Croll, New Paltz, NY (US);

Lynn Macdonald, Harrison, NY (US);

Ying Hu, Scarsdale, NY (US);

Carmelo Romano, Tarrytown, NY (US);

Assignee:

Regeneran Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/027 (2006.01); C12N 5/10 (2006.01); A61K 49/00 (2006.01); C12N 9/12 (2006.01);
U.S. Cl.
CPC ...
A01K 67/0278 (2013.01); A01K 67/0271 (2013.01); A61K 49/0008 (2013.01); C12N 5/10 (2013.01); C12N 9/12 (2013.01); C12Y 207/10001 (2013.01); A01K 2207/15 (2013.01); A01K 2217/072 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A01K 2267/0318 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/033 (2013.01); C07K 2319/035 (2013.01);
Abstract

Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized TRKB locus and methods of making and using such non-human animal genomes, non-human animal cells, and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized TRKB locus express a human TRKB protein or a chimeric transthyretin protein, fragments of which are from human TRKB. Methods are provided for using such non-human animals comprising a humanized TRKB locus to assess in vivo efficacy of human-TRKB-targeting reagents such as nuclease agents designed to target human TRKB.


Find Patent Forward Citations

Loading…